 |
|
|
| |
Characterization of HCV Resistance From a 3-Day Monotherapy Study
of GS-9857, a Novel Pangenotypic NS3/4A Protease Inhibitor
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Eric Lawitz,1 Hadas Dvory-Sobol,2 Jenny C. Yang,2 Luisa M. Stamm,2 James G. Taylor,2 Diana M. Brainard,2 Michael D. Miller,2 Hongmei Mo,2 Maribel Rodriguez-Torres3
1Alamo Medical Research, San Antonio, TX; 2Gilead Sciences, Inc., Foster City, CA; 3Fundación de Investigación, Rio Pedras, Puerto Rico
|
| |
|
|
|
|
|
